Exposure-Response Analysis of Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Agarwal, Suresh [1 ]
Gopalakrishnan, Sathej [1 ]
Mensing, Sven [1 ]
Potluri, Jalaja [1 ]
Hayslip, John [1 ]
Friedel, Anna [1 ]
Menon, Rajeev [1 ]
Salem, Ahmed Hamed [1 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5239
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
    Zhang, Keyuan
    Zhang, Xiang
    Xu, Yang
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Zhang, Yanming
    Wu, Depei
    Wang, Ying
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [42] Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
    Keyuan Zhang
    Xiang Zhang
    Yang Xu
    Shengli Xue
    Huiying Qiu
    Xiaowen Tang
    Yue Han
    Suning Chen
    Aining Sun
    Yanming Zhang
    Depei Wu
    Ying Wang
    Blood Cancer Journal, 13
  • [43] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    BLOOD, 2020, 136
  • [44] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [45] Efficacy of hypomethylating agents and Venetoclax in unfit patients with acute myeloid leukemia
    Rieger, M.
    Manz, M. G.
    Muller, R.
    Theocharides, A. P. A.
    Schwotzer, R.
    SWISS MEDICAL WEEKLY, 2020, : 17S - 17S
  • [46] Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
    Kadia, Tapan M.
    Reville, Patrick K.
    Wang, Xuemei
    Rausch, Caitlin R.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval G. G.
    DiNardo, Courtney D. D.
    Sasaki, Koji
    Issa, Ghayas C. C.
    Ohanian, Maro
    Montalban-Bravo, Guillermo
    Short, Nicholas J. J.
    Jain, Nitin
    Ferrajoli, Alessandra
    Bhalla, Kapil N. N.
    Jabbour, Elias
    Takahashi, Koichi
    Malla, Rashmi
    Quagliato, Kelly
    Kanagal-Shamanna, Rashmi
    Popat, Uday R. R.
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Konopleva, Marina Y. Y.
    Ravandi, Farhad
    Kantarjian, Hagop M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (33) : 3848 - +
  • [47] Low-dose venetoclax combined with azacitidine in older and frail patients with newly diagnosed acute myeloid leukaemia
    Rong, Chunmeng
    Yang, Fang
    Chen, Yalu
    Wang, Ming
    Ai, Cheng
    Luo, Yuqing
    Gao, Panpan
    Weng, Yiqin
    Huang, Xiaguang
    Gu, Meier
    Huang, Weiping
    Xia, Yongming
    ONCOLOGY LETTERS, 2024, 27 (05)
  • [48] Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia
    Zeidan, Amer M.
    Schuster, Michael W.
    Krauter, Jurgen
    Maertens, Johan A.
    Gyan, Emmanuel
    Joris, Magalie
    Menne, Tobias F.
    Vyas, Paresh
    Ma, Weidong Wendy
    O'Connell, Ashleigh
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Sekeres, Mikkael A.
    BLOOD, 2019, 134
  • [49] Improved Outcomes of Low-Dose Cytarabine Regimen By Increased Dose and Duration of Cytarabine in Combination with Oral Etoposide for Elderly Acute Myeloid Leukemia
    Shin, Seung-Hwan
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Kim, Hee-Je
    Jeon, Young-Woo
    Lee, Sung-Eun
    Eom, Ki-Sung
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    BLOOD, 2015, 126 (23)
  • [50] Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia
    Salhotra, Amandeep
    Tsai, Ni-Chun
    Zhang, Jianying
    Ngo, Dat
    Aribi, Ahmed
    Sandhu, Karamjeet
    Ball, Brian
    Al-Malki, Monzr
    Ali, Haris
    Koller, Paul
    Artz, Andrew
    Forman, Stephen
    Nakamura, Ryotaro
    Stein, Anthony
    Marcucci, Guido
    Aldoss, Ibrahim
    Pullarkat, Vinod
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (06) : E71 - E74
12345